In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
INDICATIONS:Immediate release formulation: moderate to severe acute pain; extended release formulation: moderate to severe chronic pain and neuropathic pain associated with diabetic peripheral neuropathy when a continuous analgesic is needed for an extended period of time
Contra-indicated in patients with impaired pulmonary function or paralytic ileus. Should not be used in patients currently using or within 14 days of using a monoamine oxidase inhibitor.
For extended release oral tablets: ABUSE POTENTIAL, LIFE-THREATENING RESPIRATORY DEPRESSION, ACCIDENTAL EXPOSURE, and INTERACTION WITH ALCOHOL
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.